261 related articles for article (PubMed ID: 16996314)
21. Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses.
Di Paolo NC; Tuve S; Ni S; Hellström KE; Hellström I; Lieber A
Cancer Res; 2006 Jan; 66(2):960-9. PubMed ID: 16424031
[TBL] [Abstract][Full Text] [Related]
22. Selectivity and efficiency of late transgene expression by transcriptionally targeted oncolytic adenoviruses are dependent on the transgene insertion strategy.
Quirin C; Rohmer S; Fernández-Ulibarri I; Behr M; Hesse A; Engelhardt S; Erbs P; Enk AH; Nettelbeck DM
Hum Gene Ther; 2011 Apr; 22(4):389-404. PubMed ID: 20939692
[TBL] [Abstract][Full Text] [Related]
23. Irradiation enhances the therapeutic effect of the oncolytic adenovirus XVir-N-31 in brain tumor initiating cells.
Czolk R; Schwarz N; Koch H; Schötterl S; Wuttke TV; Holm PS; Huber SM; Naumann U
Int J Mol Med; 2019 Oct; 44(4):1484-1494. PubMed ID: 31432139
[TBL] [Abstract][Full Text] [Related]
24. Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters.
Bortolanza S; Bunuales M; Alzuguren P; Lamas O; Aldabe R; Prieto J; Hernandez-Alcoceba R
Cancer Gene Ther; 2009 Sep; 16(9):703-12. PubMed ID: 19229289
[TBL] [Abstract][Full Text] [Related]
25. Imaging the modulation of adenoviral kinetics and biodistribution for cancer gene therapy.
Mocanu JD; Yip KW; Alajez NM; Shi W; Li JH; Lunt SJ; Moriyama EH; Wilson BC; Milosevic M; Lo KW; van Rooijen N; Busson P; Bastianutto C; Liu FF
Mol Ther; 2007 May; 15(5):921-9. PubMed ID: 17356543
[TBL] [Abstract][Full Text] [Related]
26. Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity.
Barton KN; Paielli D; Zhang Y; Koul S; Brown SL; Lu M; Seely J; Kim JH; Freytag SO
Mol Ther; 2006 Feb; 13(2):347-56. PubMed ID: 16290236
[TBL] [Abstract][Full Text] [Related]
27. Impact of human neutralizing antibodies on antitumor efficacy of an oncolytic adenovirus in a murine model.
Tsai V; Johnson DE; Rahman A; Wen SF; LaFace D; Philopena J; Nery J; Zepeda M; Maneval DC; Demers GW; Ralston R
Clin Cancer Res; 2004 Nov; 10(21):7199-206. PubMed ID: 15534093
[TBL] [Abstract][Full Text] [Related]
28. Growth inhibition of human multiple myeloma cells by an oncolytic adenovirus carrying the CD40 ligand transgene.
Fernandes MS; Gomes EM; Butcher LD; Hernandez-Alcoceba R; Chang D; Kansopon J; Newman J; Stone MJ; Tong AW
Clin Cancer Res; 2009 Aug; 15(15):4847-56. PubMed ID: 19622582
[TBL] [Abstract][Full Text] [Related]
29. Viral transgene expression delivered by repeat intraocular adenoviral vector injection: in vivo live imaging study.
Gehlbach PL; Chuck RS; Park CG; Park CY
Mol Imaging; 2012; 11(5):361-71. PubMed ID: 22954180
[TBL] [Abstract][Full Text] [Related]
30. Tumor-specific intravenous gene delivery using oncolytic adenoviruses.
Zhan J; Gao Y; Wang W; Shen A; Aspelund A; Young M; Laquerre S; Post L; Shen Y
Cancer Gene Ther; 2005 Jan; 12(1):19-25. PubMed ID: 15514685
[TBL] [Abstract][Full Text] [Related]
31. Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity.
Fernández-Ulibarri I; Hammer K; Arndt MA; Kaufmann JK; Dorer D; Engelhardt S; Kontermann RE; Hess J; Allgayer H; Krauss J; Nettelbeck DM
Int J Cancer; 2015 May; 136(9):2228-40. PubMed ID: 25303768
[TBL] [Abstract][Full Text] [Related]
32. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus replication-competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc).
Habib NA; Mitry R; Seth P; Kuppuswamy M; Doronin K; Toth K; Krajcsi P; Tollefson AE; Wold WS
Cancer Gene Ther; 2002 Aug; 9(8):651-4. PubMed ID: 12136425
[TBL] [Abstract][Full Text] [Related]
34. Anti-T cell receptor antibody prolongs transgene expression and reduces lung inflammation after adenovirus-mediated gene transfer.
Zsengellér ZK; Boivin GP; Sawchuk SS; Trapnell BC; Whitsett JA; Hirsch R
Hum Gene Ther; 1997 May; 8(8):935-41. PubMed ID: 9195216
[TBL] [Abstract][Full Text] [Related]
35. Lung-specific expression of adenovirus E3-14.7K in transgenic mice attenuates adenoviral vector-mediated lung inflammation and enhances transgene expression.
Harrod KS; Hermiston TW; Trapnell BC; Wold WS; Whitsett JA
Hum Gene Ther; 1998 Sep; 9(13):1885-98. PubMed ID: 9741427
[TBL] [Abstract][Full Text] [Related]
36. Comparative analyses of transgene delivery and expression in tumors inoculated with a replication-conditional or -defective viral vector.
Ichikawa T; Chiocca EA
Cancer Res; 2001 Jul; 61(14):5336-9. PubMed ID: 11454670
[TBL] [Abstract][Full Text] [Related]
37. Suppression of the immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposide.
Bouvet M; Fang B; Ekmekcioglu S; Ji L; Bucana CD; Hamada K; Grimm EA; Roth JA
Gene Ther; 1998 Feb; 5(2):189-95. PubMed ID: 9578838
[TBL] [Abstract][Full Text] [Related]
38. Adenoviral targeting of gene expression to tumors.
Hogg RT; Garcia JA; Gerard RD
Cancer Gene Ther; 2010 Jun; 17(6):375-86. PubMed ID: 20139924
[TBL] [Abstract][Full Text] [Related]
39. Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro.
Candolfi M; Pluhar GE; Kroeger K; Puntel M; Curtin J; Barcia C; Muhammad AK; Xiong W; Liu C; Mondkar S; Kuoy W; Kang T; McNeil EA; Freese AB; Ohlfest JR; Moore P; Palmer D; Ng P; Young JD; Lowenstein PR; Castro MG
Neuro Oncol; 2007 Jul; 9(3):245-58. PubMed ID: 17522335
[TBL] [Abstract][Full Text] [Related]
40. Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus.
Dong F; Wang L; Davis JJ; Hu W; Zhang L; Guo W; Teraishi F; Ji L; Fang B
Clin Cancer Res; 2006 Sep; 12(17):5224-30. PubMed ID: 16951242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]